Tarsus Pharmaceuticals TARS
NASDAQ TARS
$68.20 -3.88 (-5.38%)
At close: Oct 23, 2026 · 4:00 PM EDT

Tarsus Pharmaceuticals (TARS) Sale and Maturity of Investments (2023 - 2026)

Updated

Analysis

Tarsus Pharmaceuticals (TARS) Sale and Maturity of Investments (2023 - 2026) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Investments Sold (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn -
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn 308.00 Mn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn -
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn 1.30 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn 136.00 Mn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn -
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn -
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn 1.03 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn 2.12 Bn
10 Tarsus Pharmaceuticals 2.95 Bn 1.90 Bn 161.80 Mn 44.35 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 44.35 Mn
Mar 31, 2026 74.06 Mn
Dec 31, 2025 92.08 Mn
Sep 30, 2025 99.50 Mn
Jun 30, 2025 79.00 Mn
Mar 31, 2025 91.22 Mn
Dec 31, 2024 35.47 Mn
Sep 30, 2024 24.50 Mn
Jun 30, 2024 10.54 Mn
Mar 31, 2024 2.50 Mn
Sep 30, 2023 51.74 Mn
Jun 30, 2023 64.88 Mn
Mar 31, 2023 40.30 Mn
API Access

Tarsus Pharmaceuticals Sale and Maturity of Investments API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=sale-and-maturity-of-investments&ticker=TARS&period=max&api_key=YOUR_API_KEY